Close
Help
Need Help?



Emerging Risk Factors for Urologic Diseases

Submit a Paper


Libertas Analytics


1273 Article Views

Publication Date: 29 Aug 2008

Journal: Clinical Medicine Insights: Urology Clinical Medicine: Urology 2008:2 1-4

CMIu
journal

7,001 Article Views

3,262,760 Libertas Article Views

More Statistics

Abstract Modern medicine has brought us many miracle cures. In the 21st century, especially, we are blessed with increasingly powerful disease combating tools, such as functional genomics, proteomics and stem cells. Decades of medical and pharmaceutical research have produced thousands of medicines that allow us to treat and prevent diseases better than ever before. Furthermore, risk factors for many major diseases are being identified. To name a few, we now know that high cholesterol and chronic inflammation are two most prominent risk factors for cardiovascular diseases. We also know that obesity is one of the major contributing factors for type II diabetes. Cigarette smoking and air pollution are major environmental causes of respiratory diseases and lung cancers. Unfortunately, specific risk factors for many urologic diseases are yet to be identified. In this editorial, I will discuss emerging urologic risk factors based on recent research findings and their implications on what we should be looking ahead. Understanding risk factors is obviously important because it allows us to avoid disease development in the first place. Risk assessment facilitates clinical prognosis and understanding of disease development mechanisms.


Post a Comment

x close

Discussion Add A Comment
No comments yet...Be the first to comment.


share on

Our Service Promise

  • Prompt Processing (Average 3 Weeks)
  • Fair & Constructive Peer Review
  • Professional Author Service
  • High Visibility
  • High Readership
  • What Our Authors Say

Quick Links

Follow Us We make it easy to find new research papers. RSS Feeds Email Alerts Twitter

BROWSE CATEGORIES
Our Testimonials
Cancer Informatics has become an increasingly important source for research in the methodology of cancer genomics and the novel use of informatics technology. I have been impressed by the journal's contents and have been very gratified by the number of accesses to my recent publication. Cancer Informatics has filled an important gap in cancer research journals.
Dr Richard Simon (Chief, Biometric Research Branch, National Cancer Institute, USA) What our authors say